Laccourreye Ollivier, Cervini Mary Morgane, Boghossian Anita, Nguyen Dac Hung, Garcia Dominique, Mirghani Haitham
Université Paris Cité, Service D'Otorhinolaryngologie et de Chirurgie Cervico-Faciale, HEGP, Paris, France.
Laryngoscope. 2025 Aug;135(8):2863-2868. doi: 10.1002/lary.32167. Epub 2025 May 12.
To evaluate 10-year nodal outcome of active monitoring of the neck for cT2N0M0 true vocal cord (TVC) squamous cell carcinoma (SCC) after frontline partial laryngectomy (PL).
Retrospective observational study adhering to the STROBE guideline.
French academic tertiary referral care center.
Inception cohort of 81 isolated and untreated cT2N0M0 TVC SCC consecutively managed between 1983 and 2013 with frontline PL and active monitoring of the neck. 85% of patients were followed until death or for at least 10 years.
Main endpoint was 10-year actuarial nodal control analysis. Secondary endpoints were the search for potential variables increasing the risk for nodal recurrence, management of nodal recurrence, and analysis of the oncologic consequences of nodal recurrence. The significance threshold was set at p < 0.005.
The 10-year actuarial nodal control estimate was 90% with salvage treatment, yielding a 99% overall nodal control rate. On univariate analysis, none of the variables assessed significantly statistically increased the risk for nodal recurrence. The 10-year actuarial estimate of distant metastasis was 0% in patients with nodal control as compared with 35% in patients with nodal recurrence (p < 0.0001). The 10-year actuarial survival estimate was 0% in patients with nodal recurrence as compared with 67% in patients with nodal control (p < 0.0001). Among the 37 patients who died, uncontrolled SCC was the cause of death in 33% of patients who had a nodal recurrence and 3% of those who did not.
Active monitoring of the neck for cT2N0M0 TVC SCC managed with PL, although not detrimental in terms of overall nodal control, is impaired by the negative oncological impact of nodal recurrence.
评估一线部分喉切除术后对cT2N0M0真性声带鳞状细胞癌患者颈部进行主动监测的10年淋巴结转归情况。
遵循STROBE指南的回顾性观察研究。
法国学术性三级转诊护理中心。
1983年至2013年间连续接受一线部分喉切除术及颈部主动监测的81例孤立且未经治疗的cT2N0M0真性声带鳞状细胞癌患者起始队列。85%的患者随访至死亡或至少10年。
主要终点为10年精算淋巴结控制分析。次要终点为寻找增加淋巴结复发风险的潜在变量、淋巴结复发的处理以及淋巴结复发的肿瘤学后果分析。显著性阈值设定为p < 0.005。
采用挽救性治疗时,10年精算淋巴结控制率估计为90%,总体淋巴结控制率为99%。单因素分析显示,所评估的变量均未显著增加淋巴结复发风险。淋巴结得到控制的患者10年远处转移精算估计率为0%,而淋巴结复发患者为35%(p < 0.0001)。淋巴结复发患者10年精算生存率估计为0%,而淋巴结得到控制的患者为67%(p < 0.0001)。在37例死亡患者中,未控制的鳞状细胞癌是33%有淋巴结复发患者和3%无淋巴结复发患者的死亡原因。
对于接受部分喉切除术治疗的cT2N0M0真性声带鳞状细胞癌患者,颈部主动监测虽然在总体淋巴结控制方面并无不利影响,但因淋巴结复发的负面肿瘤学影响而受到损害。